Feedback / Questions
SYX-5219 - Sitryx
https://www.globenewswire.com/news-release/2024/04/10/2860630/0/en/Sitryx-nominates-SYX-5219-a-novel-oral-and-targeted-PKM2-activator-for-clinical-development-in-atopic-dermatitis.html
Apr 10, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next